In this month’s Tracking Cells podcast, we talk with TrakCel’s Alice Clayton, Head of Project Management, and Sean Evans, VP of Technical Delivery, about the intricacies, advantages and considerations of customizing cell therapy orchestration solutions. 

During this episode, we’ll explore the dynamic landscape of cell therapy orchestration, the process and planning involved in a successful deployment, as well as what and when to customize for the best results.

Furthermore, we discuss some real-world success stories and suggested solutions for common industry challenges, such as the implementation of timer-driven email notifications for efficient communication and process reminders. As well as how customizations and automations positively impact patients, reducing time to treatment and enhancing the overall patient experience.

Join us for this insightful instalment as we demystify the complexities of customizing cell therapy automation.

Explore the challenges of effective patient scheduling within CGT with Andy Case, Head of Supply Chain at Genentech Roche, and Dr Akshay Peer, Senior Vice President of Product and TrakCel co-founder. 

 Delve into the intricacies of managing frequently changing patient schedules, exploring the traditional methods and stakeholders involved. Learn how digitalization, particularly through cell orchestration, can revolutionize the patient scheduling process and improve time to treatment. 

 Join us as we navigate the evolving landscape of CGT and unravel the key to mastering patient scheduling for a more efficient and patient-centric future.

In this insightful episode, we discuss how digital collaboration and a strong eco-system play a vital role in error prevention, efficiency enhancement, and scaling up within the Cell and Gene Therapy industry.

 
We’re joined by experts Dr. Judith Koliwer, Principal Consultant of Cell and Gene Therapy at Körber and Chris Came, Vice President of Global Alliances and Client Services at TrakCel. They explore the key benefits of digital collaboration and having an eco-system within the cell and gene sector, as well as the challenges, synergies, and strategies that shape the industry's growth and emphasizes the importance of strong partnerships.

 
Listen in for an engaging look at cell and gene therapy’s digital future with a united aim of optimal patient care. 

In this compelling episode, host Helen Hopkins engages in a deep conversation with Edward Armstrong, Vice President of Quality at Mustang Bio, and Matthew Lakelin, VP of Scientific Affairs at TrakCel. Both experts bring a wealth of knowledge and experience to the table, as they explore the intricacies, challenges, and benefits of Cell and Gene Therapy (CGT).

Edward’s extensive background in CGT and quality management dovetails with Matthew's expertise in scientific affairs, giving you an enriched understanding of the topic. Together, they discuss the evolution of the CGT industry, the unique challenges posed by its clinical trials, and the groundbreaking technology that is streamlining the entire process.

Tune in to learn how this rapidly changing field impacts patient care and healthcare’s future.

In Episode Three of the Tracking Cells podcast, we go backstage for an inside peak at TrakCel. We chat with our Senior Technical Delivery Analyst, Thomas Booth, and one of our Project Managers, Adam Harvey.

In this episode, we explore in-depth the significance of Chain of Identity (COI) and Chain of Custody (COC) within the cell and gene therapy industry. We also discuss the impact of new recommendations around COI and labelling, and consider the potential implications of advancements, such as localized point of care, on the sector. 

Join Helen, Thomas and Adam as they unravel the complexities of the CGT industry ensuring you’re well-informed and ahead of the curve. 

In Episode two of the Tracking Cells Podcast, we chat to Dale Hanna, Director of Cell and Gene Therapy Solutions at AmerisourceBergen, and Imran Ahmed, Head of Product at TrakCel.

Together, they share their thoughts on essential aspects of product development and its impact on CGT therapies. They emphasize the importance of understanding patient needs and creating a seamless user experience to improve patient access and overall outcomes.

The podcast covers various key topics, including agile product development for a fast-moving sector, how supporting products and services can help ease resource crunch in the CGT supply chain, and the role of new technologies in the future.

Join us as we explore product development within the CGT supply chain with a focus on patient care and commercialization.

In this episode, we have the pleasure of chatting with Lia Sylvestri, the Director of Customer Care and Experience at TrakCel, and Dr Matthew Lakelin, one of TrakCel’s Co-Founders. 

Together, they shed light on both the challenges and potential of the rapidly evolving cell and gene therapy industry, exploring the significance of standardization, technology integration, early adoption of digitalisation, and automated cell orchestration systems. 

Join us for an engaging conversation that uncovers the dynamic landscape of cell and gene therapy industry as it matures, and the growing importance of patient care and accessibility.